Keywords: ks, biomedix, rheumatoid, arthritis, study, positive, uk

KS Biomedix' Rheumatoid Arthritis Study Positive

Article | 12 February 1998

Print This

UK biotechnology firm KS Biomedix has reported positive data from aPhase II trial of CBF-BS2, a glucose-6-phosphate dehydrogenase inhibitor, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in